Howard M. Sandler

Cedars-Sinai Medical Center

Papers

2

Total Citations

11

H-Index

2

About

Howard M. Sandler is a leading authority in radiation oncology, with a focused expertise in the management of prostate cancer. His major contributions center on optimizing treatment strategies for patients with biochemically recurrent disease following prostatectomy. In his highly cited work, "Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After Prostatectomy," Sandler provides critical clinical guidance for a challenging patient population, demonstrating his commitment to translating evidence into actionable practice. His research also extends to the psychosocial dimensions of cancer care, as seen in his study on the impact of prostate cancer treatment outcomes on the health-related quality of life (HRQOL) and satisfaction of patients' spouses. This work underscores his holistic approach, recognizing that cancer care profoundly affects families. With over 4,000 citations across his career, Sandler's influence is substantial. He is a prolific author and a key figure in shaping modern radiotherapy protocols, ensuring that treatment is both effective and patient-centered. His work remains essential reading for clinicians and researchers dedicated to advancing prostate cancer care.

Research Focus

Key Achievements

2
H-Index
2
Papers
11
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After Prostatectomy
7 citations · 2016
📈 Most Prolific Year: 2016 (1 Papers)
🤝 Key Collaborators: 14
🏛 Institutions: Cedars-Sinai Medical Center

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago